GDF15 and Hyperglycemia: Notably, different GDF15 doses were used here: a higher, supraphysiological concentration (100 nM or 3000 ng/mL) effectively rescued hyperglycemia-induced metabolomic changes, while low nanomolar doses relevant to normal or mildly elevated plasma levels enhanced OXPHOS function.